FDA Drug recall D-0691-2017
EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medi…
- FDA Drug
- Class I
- ongoing
- Published 2017-05-10
On 2017-05-10 the FDA classified a Class I recall of EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medi… by Meridian Medical Technologies A Pfizer, citing defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0691-2017 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2017-03-12 |
| Published | 2017-05-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Meridian Medical Technologies A Pfizer |
| Distribution | US |
Product
EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS: Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.
Reason
Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
Identifiers
| ndc | 49502-500-01 |
|---|---|
| ndc | 49502-500-02 |
| ndc | 49502-500-92 |
| ndc | 49502-501-01 |
| ndc | 49502-501-02 |
| ndc | 49502-501-92 |
| code_info | US lot 5GN767, expiration April 2017; lot 5GN773, expiration April 2017; lot 6GN215, expiration Sep 2017: INTERNA…US lot 5GN767, expiration April 2017; lot 5GN773, expiration April 2017; lot 6GN215, expiration Sep 2017: INTERNATIONAL lot 5GR765, expiration March 2017; lot 5GK771, expiration April 2017; lot 5ED824, expiration April 2017; and lot 6ED117, expiration *** |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0691-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.